Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones. - sprookjes - yvandenbroek - TriplyDB

Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.

Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.

http://www.wikidata.org/entity/Q34593818

about

The Cellular Bases of Antibody Responses during Dengue Virus Infection Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.Dissecting the human serum antibody response to secondary dengue virus infections In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers.A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins Germinal center reaction following cutaneous dengue virus infection in immune-competent mice Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte Model Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies Spleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection.Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site.Proteomic contributions to our understanding of vaccine and immune responses.Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool.Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies.Issues in contemporary and potential future molecular diagnostics for dengue.The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis.Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development.A novel mechanism of antibody-mediated enhancement of flavivirus infection.Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design.Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions.Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections Sequence analysis of feline immunoglobulin mRNAs and the development of a felinized monoclonal antibody specific to feline panleukopenia virus.Dengue vaccine: hypotheses to understand CYD-TDV-induced protection.Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4.The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope.Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus.Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype

P2860

Q26700056-D1B17A29-E527-4F63-B733-3B41F20F3F6C Q26700070-5A39C6AD-FADC-4716-ACDB-42EA89EF9E52 Q26995782-AFEA9A24-03B4-4381-83D9-748451FB6FDA Q27493140-0F996B98-44F5-43AB-8403-04BDC49C4546 Q27654848-0AE1AC04-7E91-41DB-BD68-B346FE8BD890 Q28114614-098A4976-F1F2-46D7-938F-150DEB8ACBC4 Q28119679-2CD65FB8-04D7-452C-932C-55F81B71669E Q28804225-6E5F7ED5-2B81-4988-957C-17F417FECAC5 Q33425879-5606260D-9B4D-435C-919F-1149D5325BD6 Q33728716-81332FD8-0B47-4C6F-AAAC-759CFCE8621B Q33867337-BDECAA92-F6D5-4B5F-99E9-4773B7FBEF3F Q35138111-40203565-255E-401A-B0C3-D45C54F9854C Q35535146-448AE9F0-5F50-4D5E-8866-1CFF389FB678 Q35753613-B4FFC35B-7796-47B8-967B-6F051DA23B4D Q35758626-68EF3766-3FFC-4AC1-9ED8-8640176445A4 Q35837150-EEC1452F-8530-431F-8DD4-46918360CE7A Q35850197-80869F2E-A29F-4CD9-894D-FFE669708F7C Q36205859-2BE5A91F-A424-4EEA-8FE8-742466148D87 Q36434210-32696867-A34A-4934-B034-3B76BF41B065 Q36464016-689F23F5-8669-4EB4-BDC7-E4ED44492BBC Q37363501-3F9A54CC-9EC0-4A77-A3FA-D89E05967E98 Q38652483-C416D637-E6C1-4B7F-87DF-24C18A018D70 Q38779406-528558F0-D34D-458E-95EE-73DA690A5C98 Q38994574-976A5CE6-AA9B-46E7-8ED7-D76981C580FE Q39535403-29CCE882-2E36-4719-BE65-53625EBA847D Q40038769-75931428-12A3-40F0-8F9F-B574499ADC9C Q40043685-39F7230C-9400-496C-8B8C-0B48BC6E9BC2 Q40044577-20D6F7C0-5F1D-44B7-8531-F061896EA1B7 Q40095659-635B6220-01D8-44A4-AF4D-3323F2DA6B86 Q40494092-0C45D9D6-B935-42CF-9291-9FA0DD9887C4 Q41923258-1DF36332-018D-47C9-91BD-40B0F7D84400 Q42985743-7095BA47-644F-4D7D-B84B-CE6FC39E2BB7 Q45323668-44B7ED32-A2BF-4165-BF4F-66410297E766 Q47558217-9EC5A3D3-0933-4B6B-9725-74AC20D1AAA8 Q52334283-9397B533-BA46-4DC5-9710-FB5269B5C80F Q55338916-D2E65F85-BB47-417D-A37E-6117C3D6B9A9 Q58580637-6D62F4A1-D8A2-4740-82AA-003345672F5E Q58699988-5AE5B35D-D400-4BF5-8F8E-30B8D27B88D5

P2860

Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.

http://www.wikidata.org/entity/Q34593818

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Isolation of dengue virus-spec ...... nal groups of antibody clones.

@ast

Isolation of dengue virus-spec ...... nal groups of antibody clones.

@en

Isolation of dengue virus-spec ...... nal groups of antibody clones.

@nl

type

label

Isolation of dengue virus-spec ...... nal groups of antibody clones.

@ast

Isolation of dengue virus-spec ...... nal groups of antibody clones.

@en

Isolation of dengue virus-spec ...... nal groups of antibody clones.

@nl

prefLabel

Isolation of dengue virus-spec ...... nal groups of antibody clones.

@ast

Isolation of dengue virus-spec ...... nal groups of antibody clones.

@en

Isolation of dengue virus-spec ...... nal groups of antibody clones.

@nl

P1433

Q34593818-E0340265-3377-433A-B10A-540DF05B68EA

P1476

Q34593818-82ADF0E2-E739-48E0-A248-89FFDB522EFE

P2093

Q34593818-121E9CD0-3007-4BC0-80F8-9F5A4BF30C3B

Q34593818-98042A0D-BD7F-41AB-A0A8-AB5FF3E21514

Q34593818-D8F5C6C6-7606-4189-8AED-3F3F7162E88B

Q34593818-ECB5FA40-AA6B-4219-9DAB-A07EF75564C8

P2860

Q34593818-032F569D-8EB8-4B21-99B2-5DEA1972CBDB

Q34593818-1244630D-1379-4A10-B11E-7CA593A297F0

Q34593818-322DD644-F98E-4C28-892F-AB7341B97D4C

Q34593818-35F5A47E-6D43-4C98-9730-3389856B575B

Q34593818-3B1C47A8-4AB3-410D-B701-65CC8DF84757

Q34593818-3E1D5184-7FB3-4AE0-9F78-1A0B83A98AE1

Q34593818-6188938B-07A2-4B54-AD69-0ECAEEA1D5F7

Q34593818-6E26A65E-F645-4213-A6D9-7D6EAB82AD43

Q34593818-7D0DB0A7-241B-45B9-AA0C-ECE6F2206CCF

Q34593818-7F26676C-519C-4354-8F30-A2CF4D87AEB8

P304

Q34593818-3AA61F44-E87C-48BB-ABB0-E0908E16CAE1

P31

Q34593818-717895F1-926F-437A-8DF9-DF899DB9AF18

P356

Q34593818-C2B90A03-E81F-4147-8892-0B7AA3D429F5

P407

Q34593818-DF19555C-F87C-42E9-AB3E-BEAA237F1A44

P433

Q34593818-EC3B4B8D-C6B6-40BA-AD3E-13996E7CB1AA

P478

Q34593818-B189DD01-24D0-491C-A365-25F58DAEDAB6

P50

Q34593818-BFBEC1CA-E801-4F73-904D-0F8629873836

Q34593818-C90E8DA4-2EE9-4302-89A9-E4CB6D40D96E

P577

Q34593818-75CCCE18-F524-49CF-A820-5F62D502E378

P5875

Q34593818-9E4DC33D-F0FE-4089-BBB6-703ED0F2355C

P698

Q34593818-D897FACC-5C24-45F5-947D-16A72FF72DCA

P921

Q34593818-5D824233-7EF4-4BB6-9A8C-01648B1A8992

Q34593818-864A2072-38AE-4FB2-87DD-5248AD3AB5C1

Q34593818-B7CBCE13-2084-4675-A761-DDAF382E8702

P932

Q34593818-4AFE265A-EFDB-4122-9D05-7CA7A6186BF1

P356

P1433

Journal of Virology

P1476

Isolation of dengue virus-spec ...... nal groups of antibody clones.

@en

P2093

A Ruklanthi de Alwis

http://www.w3.org/2001/XMLSchema#string

Nurgun Kose

http://www.w3.org/2001/XMLSchema#string

Ramesh S Jadi

http://www.w3.org/2001/XMLSchema#string

Scott A Smith

http://www.w3.org/2001/XMLSchema#string

P2860

The global distribution and burden of dengue

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

Flow cytometry-based assay for titrating dengue virus.

Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization

Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes

Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus

Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease

The structural basis for serotype-specific neutralization of dengue virus by a human antibody

P304

12233-12241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00247-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Aravinda de Silva

James E. Crowe Jr.

P577

2014-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264631233

http://www.w3.org/2001/XMLSchema#string

P698

25100837

http://www.w3.org/2001/XMLSchema#string

P921

human subject research

P932

4248927

http://www.w3.org/2001/XMLSchema#string